A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

NCT00858286 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

OTHER: Spirometry, PEF measurements and diary cards to evaluate control of Asthma

Sponsor

GlaxoSmithKline